Trends Shaping The Future Of Cell And Gene Therapy Manufacturing

The cell and gene therapy (CGT) market is rapidly expanding, with over 2,200 therapies in development worldwide and significant projected global growth. This expansion is driven by maturing pipelines, accelerating regulatory approvals, and the shift of therapeutic indications beyond rare diseases. Understand the key factors driving the market, including the rising demand for scalable manufacturing processes and the essential role of specialized partners.

Explore major trends reshaping the competitive landscape, such as consolidation and strategic diversification based on technological capability. Learn how automation, digital tools, and AI are transforming manufacturing from artisanal processes to industrialized, decentralized platforms, increasing consistency and cost-efficiency. Download the full white paper to grasp the critical role of innovation partners in navigating this dynamic environment and bringing life-saving therapies to patients at scale.